C
ISSUER//CIK 0001412067
Cascadian Therapeutics, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A117.2 KBCascadian Therapeutics, Inc.Apr 9, 4:53 PM ET·0001140361-18-017853
- SC 13D/A95.5 KBCascadian Therapeutics, Inc.Mar 19, 3:16 PM ET·0001072613-18-000224
- 8-K27.6 KBCascadian Therapeutics, Inc.Mar 9, 5:00 PM ET·0001193125-18-077500
- 10-K10.8 MBCascadian Therapeutics, Inc.Mar 8, 4:49 PM ET·0001193125-18-075320
- SC 13D/A425.4 KBCascadian Therapeutics, Inc.Mar 2, 9:53 AM ET·0001072613-18-000177
- SC 13G/A117.4 KBCascadian Therapeutics, Inc.Feb 13, 4:24 PM ET·0001140361-18-007143
- 8-K67.7 KBCascadian Therapeutics, Inc.Feb 7, 4:40 PM ET·0001193125-18-034805
- SC 13G/A196.0 KBCascadian Therapeutics, Inc.Feb 6, 11:39 AM ET·0000038777-18-000053
- SC 13G13.3 KBCascadian Therapeutics, Inc.Feb 1, 9:25 AM ET·0000215457-18-004559
- 8-K568.5 KBCascadian Therapeutics, Inc.Jan 31, 7:17 AM ET·0001193125-18-026357
Insiders
10- Ayer Capital Management, LP10% Owner
- Azelby RobertDirector
- BARRIS PETER J10% Owner
- BASKETT FOREST10% Owner
- BIOTECHNOLOGY VALUE FUND L PSee Explanation of Responses
- Biotechnology Value Trading Fund OS LPSee Explanation of Responses
- BVF INC/IL10% Owner
- BVF PARTNERS L P/IL10% Owner
- BVF Partners OS Ltd.See Explanation of Responses
- Christianson GaryChief Operating Officer
Tickers
No tickers on record
Addresses
business
3101 WESTERN AVE. SUITE 600
SEATTLE, WA, 98121
mailing
3101 WESTERN AVE. SUITE 600
SEATTLE, WA, 98121
Former Names
- Oncothyreon Inc.2016-06-09
- Biomira CORP2007-09-27